Rowlandmiller & Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.34M | Buy |
14,748
+2
| +0% | +$685 | 0.97% | 26 |
|
|
2026
Q1 | $5.19M | Sell |
14,746
-1,032
| -7% | -$368K | 1.05% | 25 |
|
|
2025
Q4 | $5.16M | Sell |
15,778
-15
| -0.1% | -$4.76K | 1% | 26 |
|
|
2025
Q3 | $4.46M | Sell |
15,793
-1,680
| -10% | -$487K | 0.88% | 31 |
|
|
2025
Q2 | $4.88M | Sell |
17,473
-115
| -0.7% | -$32.6K | 1.01% | 28 |
|
|
2025
Q1 | $5.48M | Buy |
17,588
+40
| +0.2% | +$11.8K | 1.15% | 24 |
|
|
2024
Q4 | $4.57M | Sell |
17,548
-567
| -3% | -$168K | 0.96% | 30 |
|
|
2024
Q3 | $5.84M | Sell |
18,115
-290
| -2% | -$94.9K | 1.19% | 24 |
|
|
2024
Q2 | $5.75M | Sell |
18,405
-310
| -2% | -$91.1K | 1.25% | 23 |
|
|
2024
Q1 | $5.32M | Sell |
18,715
-76
| -0.4% | -$22.2K | 1.12% | 30 |
|
|
2023
Q4 | $5.41M | Sell |
18,791
-30
| -0.2% | -$8.17K | 1.24% | 26 |
|
|
2023
Q3 | $5.06M | Sell |
18,821
-89
| -0.5% | -$22.2K | 1.25% | 26 |
|
|
2023
Q2 | $4.2M | Sell |
18,910
-65
| -0.3% | -$15.1K | 0.99% | 32 |
|
|
2023
Q1 | $4.59M | Sell |
18,975
-307
| -2% | -$75.4K | 1.11% | 31 |
|
|
2022
Q4 | $5.05M | Buy |
19,282
+355
| +2% | +$95.2K | 1.25% | 26 |
|
|
2022
Q3 | $4.27M | Buy |
18,927
+5
| +0% | +$1.21K | 1.15% | 30 |
|
|
2022
Q2 | $4.6M | Sell |
18,922
-30
| -0.2% | -$7.35K | 1.18% | 28 |
|
|
2022
Q1 | $4.58M | Sell |
18,952
-562
| -3% | -$129K | 1.06% | 30 |
|
|
2021
Q4 | $4.39M | Buy |
19,514
+59
| +0.3% | +$12.5K | 0.98% | 32 |
|
|
2021
Q3 | $4.59M | Buy |
19,455
+110
| +0.6% | +$25.3K | 1.56% | 19 |
|
|
2021
Q2 | $4.72M | Hold |
19,345
| – | – | 1.16% | 30 |
|
|
2021
Q1 | $4.81M | Sell |
19,345
-115
| -0.6% | -$27.4K | 1.26% | 28 |
|
|
2020
Q4 | $4.47M | Buy |
19,460
+191
| +1% | +$44K | 1.28% | 27 |
|
|
2020
Q3 | $3.91M | Sell |
19,269
-186
| -1% | -$46.1K | 1.57% | 17 |
|
|
2020
Q2 | $4.59M | Buy |
19,455
+186
| +1% | +$42.4K | 1.56% | 19 |
|
|
2020
Q1 | $3.91M | Sell |
19,269
-664
| -3% | -$145K | 1.57% | 17 |
|
|
2019
Q4 | $4.81M | Buy |
19,933
+885
| +5% | +$195K | 1.49% | 23 |
|
|
2019
Q3 | $3.69M | Buy |
19,048
+462
| +2% | +$88.7K | 1.25% | 29 |
|
|
2019
Q2 | $3.43M | Buy |
18,586
+175
| +1% | +$31.3K | 1.19% | 32 |
|
|
2019
Q1 | $3.5M | Buy |
18,411
+97
| +0.5% | +$18.5K | 1.25% | 29 |
|
|
2018
Q4 | $3.57M | Sell |
18,314
-230
| -1% | -$44.9K | 1.44% | 23 |
|
|
2018
Q3 | $3.84M | Sell |
18,544
-168
| -0.9% | -$33.1K | 1.39% | 27 |
|
|
2018
Q2 | $3.45M | Sell |
18,712
-445
| -2% | -$78.7K | 1.34% | 24 |
|
|
2018
Q1 | $3.28M | Sell |
19,157
-245
| -1% | -$45K | 1.3% | 25 |
|
|
2017
Q4 | $3.39M | Buy |
19,402
+300
| +2% | +$53.1K | 1.33% | 26 |
|
|
2017
Q3 | $3.55M | Sell |
19,102
-522
| -3% | -$92.5K | 1.48% | 25 |
|
|
2017
Q2 | $3.39M | Sell |
19,624
-9
| -0% | -$1.46K | 1.43% | 25 |
|
|
2017
Q1 | $3.22M | Sell |
19,633
-68
| -0.3% | -$11.3K | 1.42% | 26 |
|
|
2016
Q4 | $2.88M | Buy |
19,701
+796
| +4% | +$120K | 1.3% | 27 |
|
|
2016
Q3 | $3.15M | Sell |
18,905
-365
| -2% | -$61.7K | 1.46% | 25 |
|
|
2016
Q2 | $2.94M | Sell |
19,270
-216
| -1% | -$33.6K | 1.35% | 26 |
|
|
2016
Q1 | $2.92M | Buy |
19,486
+7
| +0% | +$1.04K | 1.38% | 24 |
|
|
2015
Q4 | $3.07M | Sell |
19,479
-16
| -0.1% | -$2.52K | 1.56% | 19 |
|
|
2015
Q3 | $2.64M | Sell |
19,495
-562
| -3% | -$88.6K | 1.4% | 23 |
|
|
2015
Q2 | $3.08M | Sell |
20,057
-627
| -3% | -$100K | 1.53% | 22 |
|
|
2015
Q1 | $3.23M | Sell |
20,684
-1,144
| -5% | -$180K | 1.61% | 21 |
|
|
2014
Q4 | $3.48M | Buy |
+21,828
| New | +$3.4M | 1.69% | 21 |
|
Other funds holding AMGN
Rowlandmiller & Partners's AMGN Position: Q2 2026 in Review
Rowlandmiller & Partners increased its Amgen (AMGN) stake by 0.01% in Q2 2026, buying an estimated $685 and bringing the position to 14,748 shares worth $5.34M. The position accounts for 0.97% of the portfolio, ranked #26.
Rowlandmiller & Partners first reported a position in AMGN in Q4 2014 and has held it in 47 quarters since. The position peaked at $5.84M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Rowlandmiller & Partners held 14,748 shares of Amgen worth $5.34M as of Q2 2026.
- Rowlandmiller & Partners bought 2 Amgen shares in Q2 2026, an estimated $685.
- Amgen made up 0.97% of Rowlandmiller & Partners's portfolio in Q2 2026, its #26 holding.
- Rowlandmiller & Partners first reported a position in Amgen in Q4 2014 and has held it in 47 quarters since.
- Rowlandmiller & Partners's Amgen position peaked at $5.84M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Rowlandmiller & Partners's 13F filing for Q2 2026, filed 23 Jul 2026.